Skip to main content

3D Living Tissues

Project description

A bioprinted 3D lymph node model for drug discovery

More than 90 % of oncology drugs fail in clinical trials. This is attributed to the unreliable in vitro models used for drug discovery. The scope of the EU-funded 3DLT project is to bring to market a proprietary 3D bioprinting technology that uses live human cells to generate tissues that closely resemble their human counterparts. Researchers have developed a 3D lymph node as a platform for testing new immunotherapies against cancer. The project's work includes assessing the economic feasibility of bringing the product to market, and making the necessary industrial and commercial partnerships to reach this objective.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 50 000,00
Via Trento 30
43122 Parma

See on map

Nord-Est Emilia-Romagna Parma
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00